These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10965574)

  • 1. [Treatment of genital herpes with alfa-2b interferon].
    Granados Loarca EA; Estrada Barrondo EA
    Actas Urol Esp; 2000 May; 24(5):388-92. PubMed ID: 10965574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of recurrent genital herpes with interferon alpha-2alpha.
    Cardamakis E; Relakis K; Kotoulas IG; Michopoulos J; Metallinos K; Mantouvalos H; Tzingounis V
    Gynecol Obstet Invest; 1998; 46(1):54-7. PubMed ID: 9692344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy.
    Kraus MR; Schäfer A; Faller H; Csef H; Scheurlen M
    J Clin Psychiatry; 2003 Jun; 64(6):708-14. PubMed ID: 12823087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetic analysis of pegylated interferon alfa-2b and interferon alfa-2b in patients with chronic hepatitis C.
    Jen JF; Glue P; Ezzet F; Chung C; Gupta SK; Jacobs S; Hajian G
    Clin Pharmacol Ther; 2001 Jun; 69(6):407-21. PubMed ID: 11406738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.
    Carrat F; Bani-Sadr F; Pol S; Rosenthal E; Lunel-Fabiani F; Benzekri A; Morand P; Goujard C; Pialoux G; Piroth L; Salmon-Céron D; Degott C; Cacoub P; Perronne C;
    JAMA; 2004 Dec; 292(23):2839-48. PubMed ID: 15598915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albinterferon alfa-2b, a novel fusion protein of human albumin and human interferon alfa-2b, for chronic hepatitis C.
    Rustgi VK
    Curr Med Res Opin; 2009 Apr; 25(4):991-1002. PubMed ID: 19275518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic hepatitis C in HIV infection: feasibility and sustained efficacy of therapy with interferon alfa-2b and tribavirin.
    Nasti G; Di Gennaro G; Tavio M; Cadorin L; Tedeschi RM; Talamini R; Carbone A; Tirelli U
    AIDS; 2001 Sep; 15(14):1783-7. PubMed ID: 11579239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study.
    Farrell GC; Bacon BR; Goldin RD
    Hepatology; 1998 Apr; 27(4):1121-7. PubMed ID: 9537453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hepatitis B-related polyarteritis nodosa with famciclovir and interferon alfa-2b.
    Kruger M; Böker KH; Zeidler H; Manns MP
    J Hepatol; 1997 Apr; 26(4):935-9. PubMed ID: 9126810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon found helpful in herpes genitalis case.
    Dungwa N
    S Afr Med J; 1997 Apr; 87(4):475. PubMed ID: 9254804
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of Adamantiades-Behçet disease with systemic interferon alfa.
    Zouboulis CC; Orfanos CE
    Arch Dermatol; 1998 Aug; 134(8):1010-6. PubMed ID: 9722733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preliminary study on the efficacy and influencing factors of interferon for the treatment of genotype 1 chronic hepatitis C with different dosage forms.
    Ma P; Yang JM; Hou W; Song SD; Wang L; Lu W
    Eur J Gastroenterol Hepatol; 2013 May; 25(5):601-5. PubMed ID: 23263720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decorin and actin expression and distribution in patients with chronic hepatitis C following interferon-alfa-2b treatment.
    Jármay K; Gallai M; Karácsony G; Ozsvár Z; Schaff Z; Lonovics J; Kovalszky I
    J Hepatol; 2000 Jun; 32(6):993-1002. PubMed ID: 10898320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China.
    Sun J; Ding H; Chen G; Wang G; Wei L; Zhang J; Xie Q; Wan M; Tang H; Chen S; Gao Z; Wang Y; Zhang D; Huang W; Sheng J; Ning Q; Yang D; Lu J; Pan C; Yang Y; Wang J; Sun C; Wang Q; Hou J
    BMC Gastroenterol; 2019 May; 19(1):65. PubMed ID: 31046700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon alpha-2B and ribavirin in combination for patients with chronic hepatitis C who failed to respond to, or relapsed after, interferon alpha therapy: a randomized trial.
    Barbaro G; Di Lorenzo G; Belloni G; Ferrari L; Paiano A; Del Poggio P; Bacca D; Fruttaldo L; Mongiò F; Francavilla R; Scotto G; Grisorio B; Calleri G; Annese M; Barelli A; Rocchetto P; Rizzo G; Gualandi G; Poltronieri I; Barbarini G
    Am J Med; 1999 Aug; 107(2):112-8. PubMed ID: 10460040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of generalized lichen planus with recombinant interferon alfa-2b.
    Hildebrand A; Kolde G; Luger TA; Schwarz T
    J Am Acad Dermatol; 1995 Nov; 33(5 Pt 2):880-3. PubMed ID: 7593801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Local treatments using antiviral and non-antiviral drugs for herpes facialis and genitalis (excluding pregnant females and neonates at risk)].
    Chosidow O; Lebrun-Vignes B
    Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 2):635-45. PubMed ID: 12122334
    [No Abstract]   [Full Text] [Related]  

  • 18. A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C.
    Lindsay KL; Trepo C; Heintges T; Shiffman ML; Gordon SC; Hoefs JC; Schiff ER; Goodman ZD; Laughlin M; Yao R; Albrecht JK;
    Hepatology; 2001 Aug; 34(2):395-403. PubMed ID: 11481625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokinetics.
    González-Peralta RP; Kelly DA; Haber B; Molleston J; Murray KF; Jonas MM; Shelton M; Mieli-Vergani G; Lurie Y; Martin S; Lang T; Baczkowski A; Geffner M; Gupta S; Laughlin M;
    Hepatology; 2005 Nov; 42(5):1010-8. PubMed ID: 16250032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
    Fried MW; Shiffman ML; Reddy KR; Smith C; Marinos G; Gonçales FL; Häussinger D; Diago M; Carosi G; Dhumeaux D; Craxi A; Lin A; Hoffman J; Yu J
    N Engl J Med; 2002 Sep; 347(13):975-82. PubMed ID: 12324553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.